Skip to content

Clinical and Pathological Characteristics of Women With Ovarian Cancers in Syria

Clinical and Pathological Characteristics of Women With Ovarian Cancers, A National, Retrospective Cross-Sectional Study in Syria During the War

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06253559
Enrollment
531
Registered
2024-02-12
Start date
2017-01-01
Completion date
2023-12-24
Last updated
2024-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Cancer

Brief summary

the goal of this observational study is to describe ovarian cancer epidemiology and characteristics in Syrian women, especially during the war to do more research in the future about the risk factors of ovarian cancer.

Detailed description

Ovarian cancer (OC) is the eighth most common cause of death worldwide, and current studies show that the death numbers caused by it will rise dramatically in the coming years. As the epidemiological features of the cancer may vary, studying these different characteristics can help us improve treatment outcomes and add preventive measures. In addition, giving special attention to these features in developing countries, or countries undergoing crisis, will help us understand the associated risk factors in these regions.

Interventions

None listed

Sponsors

Tishreen University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* female adult (age ≥18 years) * primary ovarian malignancy

Exclusion criteria

* less than 18 years old * women who have benign tumors or metastatic ovarian cancer.

Design outcomes

Primary

MeasureTime frameDescription
symptoms of ovarian cancerjan 2017 - july 2021detect symptoms of disease at diagnosis time
Cancer Antigen-125jan 2017 - july 2021Cancer Antigen-125 levels, if they are normal or high in ovarian cancer.
Treatmentjan 2017 - july 2021detect if the patient underwent surgery or chemotherapy or the both
agejan 2017 - july 2021the age of patients at the time of diagnosis
ovarian cancer gradejan 2017 - july 2021ovarian cancer grades frequency among patients
histological type of ovarian cancerjan 2017 - july 2021detect the most common type of ovarian cancer
sideness of ovarian cancerjan 2017 - july 2021study the frequency of bilateral or unilateral ovarian cancer

Countries

Syria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026